SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 35,000
+650 (1.89%)
Jul 27, 2026, 12:50 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 2.69 trillion as of July 24, 2026. Its market cap has decreased by -27.14% in one year.
Market Cap
2.69T
Enterprise Value
2.60T
Revenue
665.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
35,000.00
ChartMarket Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 2.69T, a decrease of -79.15%. That is a compound annual growth rate of -25.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 2.69T | -28.67% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.31T |
| HLB Co., Ltd. | 4.16T |
| LigaChem Biosciences | 3.75T |
| D&D Pharmatech | 2.73T |
| Peptron | 2.64T |
| Hugel | 2.53T |
| OliX Pharmaceuticals | 2.30T |
| Voronoi | 2.29T |